Corresponding Author: Haytham M. A. Kaafarani, MD, MPH, Harvard Medical School, Division of Trauma, Emergency Surgery, and Surgical Critical Care, 165 Cambridge St, Ste 810, Boston, MA 02114 (email@example.com).
Accepted for Publication: September 14, 2020.
Published Online: September 24, 2020. doi:10.1001/jama.2020.19400
Correction: This article was corrected on March 16, 2021, to fix the median (interquartile range) days on opioid drip reported in the Table for patients with acute respiratory distress syndrome with and without COVID-19.
Author Contributions: Dr Kaafarani had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: El Moheb, Naar, Christensen, Maurer, Kaafarani.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: El Moheb, Farhat, Kaafarani.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: El Moheb, Naar, Christensen, Maurer, Farhat, Kaafarani.
Administrative, technical, or material support: Kaafarani.
Supervision: Maurer, Farhat, Kaafarani.
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank George Velmahos, MD, PhD, Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital, Boston, for his clinical expertise and advice. Dr Velmahos was not compensated for his contributions.
JS , Ng
JH , Ross
et al; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int
. 2020;98(1):209-218. doi:10.1016/j.kint.2020.05.006PubMedGoogle ScholarCrossref
VM , Rubenfeld
GD , Thompson
et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA
. 2012;307(23):2526-2533.PubMedGoogle Scholar